| Dr Solomon I Rosenblatt, MD | |
|
1949 W 12 Mile Rd, Ste 200, Berkley, MI 48072-1868 | |
| (248) 543-3700 | |
| (248) 543-4180 |
| Full Name | Dr Solomon I Rosenblatt |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 1949 W 12 Mile Rd, Berkley, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265513576 | NPI | - | NPPES |
| 2598871 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 4301049826 (Michigan) | Primary |
| Entity Name | Michigan Endocrine Consultants Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225103419 PECOS PAC ID: 2466357496 Enrollment ID: O20031203000608 |
News Archive
Insulin resistance, a condition in which insulin produced by the body becomes less effective in reducing blood glucose levels, appears to be associated with an increased risk of stroke in individuals without diabetes, according to a report in the October issue of Archives of Neurology, one of the JAMA/Archives journals.
In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.
Morbid obesity affects the liver: Almost one-third of all adults suffer from chronic fatty liver disease, which can lead to infections and even trigger cancer. Researchers at the University Children's Hospital Zurich and the University of Zurich have now found a signaling pathway in cells that play an important role in the development of fatty liver disease.
A recent study by US researchers reveals that brilacidin, a small synthetic molecule with peptide-like properties, exerts potent in vitro antiviral activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – both as a standalone treatment and in combination with FDA-approved remdesivir. The study is currently available on the bioRxiv preprint server.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Solomon I Rosenblatt, MD 1949 W 12 Mile Rd, Ste 200, Berkley, MI 48072-1868 Ph: (248) 543-3700 | Dr Solomon I Rosenblatt, MD 1949 W 12 Mile Rd, Ste 200, Berkley, MI 48072-1868 Ph: (248) 543-3700 |
News Archive
Insulin resistance, a condition in which insulin produced by the body becomes less effective in reducing blood glucose levels, appears to be associated with an increased risk of stroke in individuals without diabetes, according to a report in the October issue of Archives of Neurology, one of the JAMA/Archives journals.
In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.
Morbid obesity affects the liver: Almost one-third of all adults suffer from chronic fatty liver disease, which can lead to infections and even trigger cancer. Researchers at the University Children's Hospital Zurich and the University of Zurich have now found a signaling pathway in cells that play an important role in the development of fatty liver disease.
A recent study by US researchers reveals that brilacidin, a small synthetic molecule with peptide-like properties, exerts potent in vitro antiviral activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – both as a standalone treatment and in combination with FDA-approved remdesivir. The study is currently available on the bioRxiv preprint server.
› Verified 5 days ago
Dr. Armen A Korkigian, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2635 Coolidge Hwy, Berkley, MI 48072 Phone: 248-541-2512 Fax: 248-541-0232 | |
Dr. Maher Rabah, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 27901 Woodward Ave, Suite 300, Berkley, MI 48072 Phone: 248-545-0070 Fax: 248-545-4850 | |
Dr. Amy Klein, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1949 W 12 Mile Rd Ste 100, Berkley, MI 48072 Phone: 515-441-0811 | |
Philip Sciturro, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1695 W. 12 Mile Road, Suite 200, Berkley, MI 48072 Phone: 248-548-9090 Fax: 248-548-8462 | |
Dr. William A Briggs, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1695 12 Mile Rd, Ste 250, Berkley, MI 48072 Phone: 248-414-3210 Fax: 248-414-5227 | |
John C Stephens, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 27901 Woodward Ave Ste 300, Beaumont Northpointe Heart Center, Berkley, MI 48072 Phone: 248-545-0070 Fax: 248-545-4850 | |
Daniel Gerard Walsh, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 27901 Woodward Ave Ste 300, Berkley, MI 48072 Phone: 248-545-0070 Fax: 248-545-4850 |